Literature DB >> 22461106

Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.

Lielin Wu1, Zhiming Wang, Rongli Lu, Wei Jiang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22461106     DOI： 10.1007/s12253-012-9514-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors.

Authors:  P Rogalla; K Drechsler; G Frey; Y Hennig; B Helmke; U Bonk; J Bullerdiek
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

3.  HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.

Authors:  Monica Fedele; Rosa Visone; Ivana De Martino; Giancarlo Troncone; Dario Palmieri; Sabrina Battista; Andrea Ciarmiello; Pierlorenzo Pallante; Claudio Arra; Rosa Marina Melillo; Kristian Helin; Carlo Maria Croce; Alfredo Fusco
Journal:  Cancer Cell       Date:  2006-06       Impact factor: 31.743

4.  HMGA2 overexpression in non-small cell lung cancer.

Authors:  Britta Meyer; Siegfried Loeschke; Anke Schultze; Thomas Weigel; Martin Sandkamp; Torsten Goldmann; Ekkehard Vollmer; Jörn Bullerdiek
Journal:  Mol Carcinog       Date:  2007-07       Impact factor: 4.784

Review 5.  The HMGA proteins: a myriad of functions (Review).

Authors:  Isabelle Cleynen; Wim J M Van de Ven
Journal:  Int J Oncol       Date:  2008-02       Impact factor: 5.650

6.  Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.

Authors:  Kazuo Motoyama; Hiroshi Inoue; Yoshito Nakamura; Hiroyuki Uetake; Kenichi Sugihara; Masaki Mori
Journal:  Clin Cancer Res       Date:  2008-04-15       Impact factor: 12.531

7.  HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma.

Authors:  Alexandra C Hristov; Leslie Cope; Marcelo Delos Reyes; Mansher Singh; Christine Iacobuzio-Donahue; Anirban Maitra; L M S Resar
Journal:  Mod Pathol       Date:  2008-08-29       Impact factor: 7.842

8.  Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains.

Authors:  H R Ashar; M S Fejzo; A Tkachenko; X Zhou; J A Fletcher; S Weremowicz; C C Morton; K Chada
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

9.  Increased expression of high mobility group A proteins in lung cancer.

Authors:  V K Sarhadi; H Wikman; K Salmenkivi; E Kuosma; T Sioris; J Salo; A Karjalainen; S Knuutila; S Anttila
Journal:  J Pathol       Date:  2006-06       Impact factor: 7.996

10.  An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue.

Authors:  N Abe; T Watanabe; Y Suzuki; N Matsumoto; T Masaki; T Mori; M Sugiyama; G Chiappetta; A Fusco; Y Atomi
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640
View more
  8 in total

1.  High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.

Authors:  Zhuoxing Liu; Kunpeng Wu; Zhixiong Yang; Aibing Wu
Journal:  Mol Cell Biochem       Date:  2015-07-17       Impact factor: 3.396

2.  Weighted gene co-expression network analysis and prognostic analysis identifies hub genes and the molecular mechanism related to head and neck squamous cell carcinoma.

Authors:  Qiuli Li; Weichao Chen; Ming Song; Wenkuan Chen; Zhongyuan Yang; Ankui Yang
Journal:  Cancer Biol Ther       Date:  2019-03-22       Impact factor: 4.742

3.  Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway.

Authors:  Wei Ou; Jie Lv; Xiaohua Zou; Yin Yao; Jinli Wu; Jian Yang; Zhumei Wang; Yan Ma
Journal:  Exp Ther Med       Date:  2017-03-22       Impact factor: 2.447

4.  MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2.

Authors:  Hongzhang Cui; Ruijin Song; Ju Wu; Wei Wang; Xi Chen; Jiajun Yin
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

5.  TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma.

Authors:  Kiyokazu Shirai; Genta Nagae; Motoaki Seki; Yotaro Kudo; Asuka Kamio; Akimasa Hayashi; Atsushi Okabe; Satoshi Ota; Shuichi Tsutsumi; Takanori Fujita; Shogo Yamamoto; Ryo Nakaki; Yasuharu Kanki; Tsuyoshi Osawa; Yutaka Midorikawa; Keisuke Tateishi; Masao Ichinose; Hiroyuki Aburatani
Journal:  Cancer Sci       Date:  2021-05-10       Impact factor: 6.716

6.  High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis.

Authors:  Dan Nie; Lingping Zhang; Qian Guo; Xiguang Mao
Journal:  Oncotarget       Date:  2017-12-10

7.  Prognostic Value of HMGA2 in Human Cancers: A Meta-Analysis Based on Literatures and TCGA Datasets.

Authors:  Ben Huang; Jiayi Yang; Qingyuan Cheng; Peipei Xu; June Wang; Zheng Zhang; Wei Fan; Ping Wang; Mingxia Yu
Journal:  Front Physiol       Date:  2018-06-26       Impact factor: 4.566

8.  Tumor-Linked Macrophages Promote HCC Development by Mediating the CCAT1/Let-7b/HMGA2 Signaling Pathway.

Authors:  Liang Deng; Shan Huang; Bin Chen; Yajun Tang; Fei Huang; Dong Li; Di Tang
Journal:  Onco Targets Ther       Date:  2020-12-14       Impact factor: 4.147
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.